Perspectives on mammalian cardiovascular aging: humans to molecules
- 28 May 2002
- journal article
- review article
- Published by Elsevier in Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology
- Vol. 132 (4) , 699-721
- https://doi.org/10.1016/s1095-6433(02)00124-1
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.Journal of Clinical Investigation, 1998
- Age-Dependent Changes in the β-Adrenoceptor—G-Protein(s)—Adenylyl Cyclase System in Human Right AtriumJournal of Cardiovascular Pharmacology, 1995
- Aging, Cardiac Proenkephalin mRNA and Enkephalin Peptides in the Fisher 344 RatJournal of Molecular and Cellular Cardiology, 1994
- Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids.Proceedings of the National Academy of Sciences, 1994
- Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat.Circulation Research, 1994
- Thyroid Hormone Influences Beta Myosin Heavy Chain (βMHC) ExpressionBiochemical and Biophysical Research Communications, 1994
- Transforming growth factor-beta in disease: the dark side of tissue repair.Journal of Clinical Investigation, 1992
- TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loopCell, 1990
- Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart.Circulation Research, 1990
- Detection of hydroxyl radical in the mitochondria of ischemic-reperfused myocardium by trapping with salicylateBiochemical and Biophysical Research Communications, 1989